Bio-Rad Laboratories, Inc. (BIO): Price and Financial Metrics


Bio-Rad Laboratories, Inc. (BIO): $507.84

2.26 (+0.45%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

BIO POWR Grades


  • BIO scores best on the Sentiment dimension, with a Sentiment rank ahead of 94.92% of US stocks.
  • The strongest trend for BIO is in Growth, which has been heading down over the past 179 days.
  • BIO ranks lowest in Momentum; there it ranks in the 5th percentile.

BIO Stock Summary

  • BIO has a market capitalization of $17,419,481,037 -- more than approximately 86.32% of US stocks.
  • Bio-Rad Laboratories Inc's stock had its IPO on January 1, 1986, making it an older stock than 92.84% of US equities in our set.
  • With a price/earnings ratio of 4.1, Bio-Rad Laboratories Inc P/E ratio is greater than that of about only 4.11% of stocks in our set with positive earnings.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Bio-Rad Laboratories Inc are AGCO, ELSE, MFGP, GENC, and MOG.A.
  • Visit BIO's SEC page to see the company's official filings. To visit the company's web site, go to www.bio-rad.com.

BIO Valuation Summary

  • In comparison to the median Healthcare stock, BIO's EV/EBIT ratio is 84.64% lower, now standing at 4.5.
  • BIO's price/sales ratio has moved up 7.4 over the prior 243 months.
  • Over the past 243 months, BIO's price/earnings ratio has gone down 9.8.

Below are key valuation metrics over time for BIO.

Stock Date P/S P/B P/E EV/EBIT
BIO 2021-08-31 8.3 2.1 5.9 4.5
BIO 2021-08-30 8.4 2.1 6.0 4.5
BIO 2021-08-27 8.2 2.0 5.8 4.4
BIO 2021-08-26 8.2 2.0 5.9 4.4
BIO 2021-08-25 8.3 2.1 5.9 4.4
BIO 2021-08-24 8.2 2.0 5.8 4.4

BIO Growth Metrics

    Its 3 year cash and equivalents growth rate is now at 12.95%.
  • The 3 year net cashflow from operations growth rate now stands at 92.94%.
  • Its 3 year revenue growth rate is now at 13.58%.
Over the past 34 months, BIO's revenue has gone up $630,670,000.

The table below shows BIO's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 2,922.545 656.521 4,245.902
2021-09-30 2,979.615 783.331 6,658.663
2021-06-30 2,879.829 688.632 4,045.454
2021-03-31 2,700.778 626.13 4,097.769
2020-12-31 2,545.626 575.328 3,806.267
2020-09-30 2,380.215 450.396 3,520.651

BIO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • BIO has a Quality Grade of B, ranking ahead of 77.91% of graded US stocks.
  • BIO's asset turnover comes in at 0.192 -- ranking 66th of 75 Measuring and Control Equipment stocks.
  • AATC, HTGM, and WAT are the stocks whose asset turnover ratios are most correlated with BIO.

The table below shows BIO's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.192 0.570 0.617
2021-06-30 0.213 0.566 0.439
2021-03-31 0.220 0.563 0.497
2020-12-31 0.233 0.565 0.520
2020-09-30 0.245 0.550 0.549
2020-06-30 0.270 0.544 0.346

BIO Price Target

For more insight on analysts targets of BIO, see our BIO price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $856.25 Average Broker Recommendation 1.25 (Strong Buy)

BIO Stock Price Chart Interactive Chart >

Price chart for BIO

BIO Price/Volume Stats

Current price $507.84 52-week high $832.70
Prev. close $505.58 52-week low $462.61
Day low $502.91 Volume 171,275
Day high $511.71 Avg. volume 224,047
50-day MA $513.26 Dividend yield N/A
200-day MA $640.62 Market Cap 15.21B

Bio-Rad Laboratories, Inc. (BIO) Company Bio


Bio-Rad Laboratories manufactures and supplies products and systems used to separate complex chemical and biological materials, as well as to identify, analyze, and purify their components for life science research, healthcare, analytical chemistry, and other markets. The company operates through two segments, Life Science and Clinical Diagnostics. The company was founded in 1952 and is based in Hercules, California.


BIO Latest News Stream


Event/Time News Detail
Loading, please wait...

BIO Latest Social Stream


Loading social stream, please wait...

View Full BIO Social Stream

Latest BIO News From Around the Web

Below are the latest news stories about Bio-Rad Laboratories Inc that investors may wish to consider to help them evaluate BIO as an investment opportunity.

Bio-Rad Laboratories Up 7% After Investor Day

https://www.investing.com/news/stock-market-news/biorad-laboratories-up-7-after-investor-day-2772756

Investing.com | February 25, 2022

Bio-Rad Presents Growth Strategy and Acceleration of Financial Targets at Investor Day

HERCULES, Calif., February 25, 2022--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, is hosting an in-person investor day beginning at 10:30 a.m. EST today in New York City. During the event, members of Bio-Rad’s executive leadership team will provide an in-depth overview of the Company’s growth strategy and new long-term financial targets, as well a closer look at the drivers within the two core business segments – Life

Yahoo | February 25, 2022

Myriad Genetics (MYGN) Reports Loss in Q4, Gross Margin Improves

Strength in Myriad Genetics' (MYGN) Molecular Diagnostic segment has drove Q4 sales despite a challenging business environment.

Yahoo | February 25, 2022

Here's How Much You'd Have If You Invested $1000 in Bio-Rad Laboratories a Decade Ago

Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.

Yahoo | February 25, 2022

Integra's (IART) Q4 Earnings Top Estimates, Gross Margin Drops

Integra (IART) records strong recovery in order demand in Q4 on broad-based strength in Neurosurgery and sales from the company's new CereLink ICP monitoring.

Yahoo | February 24, 2022

Read More 'BIO' Stories Here

BIO Price Returns

1-mo -0.14%
3-mo -10.01%
6-mo N/A
1-year -19.63%
3-year 68.45%
5-year 128.24%
YTD -32.79%
2021 29.61%
2020 57.54%
2019 59.34%
2018 -2.70%
2017 30.94%

Continue Researching BIO

Want to see what other sources are saying about Bio-Rad Laboratories Inc's financials and stock price? Try the links below:

Bio-Rad Laboratories Inc (BIO) Stock Price | Nasdaq
Bio-Rad Laboratories Inc (BIO) Stock Quote, History and News - Yahoo Finance
Bio-Rad Laboratories Inc (BIO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.554 seconds.